CLINICAL OUTCOMES OF DAPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A META-ANALYSIS OF RANDOMISED CONTROLLED CLINICAL TRIALS

被引：0
|
作者：
Raval, A. [1 ]
Thakker, D. [2 ]
Undela, K. [3 ]
Vyas, A. [1 ]
Kachhadiya, R. [4 ]
Ubhadiya, B. [5 ]
机构：
[1] W Virginia Univ, Morgantown, WV 26506 USA
[2] Capita India Pvt Ltd, Bombay, Maharashtra, India
[3] JSS Coll Pharm, Mysore, Karnataka, India
[4] Cadila Healthcare Ltd, Ahmadabad, Gujarat, India
[5] Shrimati Kaumudiniben Hlth Outcomes Res Grp, Dhrangadhra, India
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.1401
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB15
引用
收藏
页码：A240 / A240
页数：1
相关论文
共 50 条
  • [1] The efficacy of dapagliflozin combined with hypoglycaemic drugs in treating type 2 diabetes mellitus: meta-analysis of randomised controlled trials
    Sun, Yu-nan
    Zhou, Yi
    Chen, Xi
    Che, Weng-si
    Leung, Siu-wai
    [J]. BMJ OPEN, 2014, 4 (04):
  • [2] Efficacy and safety of dapagliflozin as monotherapy in patients with type 2 diabetes mellitus A meta-analysis of randomized controlled trials
    Feng, Miao
    Lv, Haihong
    Xu, Xia
    Wang, Jue
    Lyu, Wenyi
    Fu, Songbo
    [J]. MEDICINE, 2019, 98 (30)
  • [3] BROMOCRIPTINE FOR THE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A META-ANALYSIS OF RANDOMIZED CONTROLLED CLINICAL TRIALS
    Dasari, A.
    Gudala, K.
    Bansal, D.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S13 - S13
  • [4] SAFETY OF DAPAGLIFLOZIN IN CLINICAL TRIALS FOR TYPE 2 DIABETES MELLITUS
    Ptaszynska, Agata
    Johnsson, Kristina
    Apanovitch, Anne Marie
    Sugg, Jennifer
    Parikh, Shamik
    List, James
    [J]. INTERNAL MEDICINE JOURNAL, 2013, 43 : 50 - 50
  • [5] Safety of dapagliflozin in clinical trials for type 2 diabetes mellitus
    Johnsson, K.
    Ptaszynska, A.
    Apanovitch, A.
    Sugg, J. E.
    Parikh, S. J.
    List, J. F.
    [J]. DIABETOLOGIA, 2012, 55 : S304 - S304
  • [6] Examination of the cardiovascular safety of pramlintide with a meta-analysis of five controlled clinical trials in patients with type 2 diabetes mellitus
    Chen, S.
    Burns, C.
    Shan, K.
    Dong, H.
    Herrmann, K.
    Miller, S.
    Yushmanova, I.
    [J]. DIABETOLOGIA, 2010, 53
  • [7] Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus: meta-analysis of randomised controlled trials
    Allemann, S
    Diem, P
    Egger, M
    Christ, ER
    Stettler, C
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (03) : 617 - 623
  • [8] Sitagliptin and risk of hypertension in patients with type 2 diabetes mellitus: meta-analysis of randomised trials
    Zhang, B.
    Lu, Z.
    [J]. DIABETOLOGIA, 2015, 58 : S547 - S548
  • [9] Effects of dapagliflozin in the progression of atherosclerosis in patients with type 2 diabetes: a meta-analysis of randomized controlled trials
    Qian-Long Wu
    Zheng, Ting
    Sheng-Zhen Li
    Jin-An Chen
    Zi-Chun Xie
    Jian-Mei Lai
    Ji-Yuan Zeng
    Jin-Ting Lin
    Jia-Shuan Huang
    Min-Hua Lin
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01):
  • [10] Effects of dapagliflozin in the progression of atherosclerosis in patients with type 2 diabetes: a meta-analysis of randomized controlled trials
    Qian-Long Wu
    Ting Zheng
    Sheng-Zhen Li
    Jin-An Chen
    Zi-Chun Xie
    Jian-Mei Lai
    Ji-Yuan Zeng
    Jin-Ting Lin
    Jia-Shuan Huang
    Min-Hua Lin
    [J]. Diabetology & Metabolic Syndrome, 14
12345